I’m keeping an eye on JHX shares in 2026

Company Overview - James Hardie Industries is a building solutions company and the world's largest producer of fibre cement and gypsum products, operating across North America, Europe, Australia, and New Zealand with over 5,200 employees [1] - CSL is a global biotechnology company focused on creating and delivering life-saving medicines, with three main divisions: CSL Behring, CSL Seqirus, and CSL Vifor [3][4] Financial Performance - The share price of James Hardie Industries (ASX:JHX) has decreased by approximately 35.0% since the start of 2025, while CSL's share price is 5.7% above its 52-week low [1] - James Hardie Industries currently has a price-sales ratio of 3.20x, lower than its 5-year average of 4.14x, indicating that shares are trading below historical averages despite revenue growth over the last three years [7] - CSL has a trailing dividend yield of around 2.23%, which is higher than its 5-year average of 1.50%, reflecting the company's stability and ability to pay out income [8] Product Characteristics - The main selling point of fibre cement for buildings includes its non-combustibility, resistance to water and termite damage, durability, and low maintenance requirements [2] Investment Appeal - James Hardie Industries is viewed as a growth company, while CSL is considered a 'blue chip' company, making both attractive options for investors seeking exposure to their respective sectors [6][5]